Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Samira El Zind

Neurology with Special Qualifications in Child Neurology South Bend, IN Medical Doctor

NPI 1326065285 CMS profile 331927

100 Navarre Pl Ste 5550, South Bend, IN 46601

Open in the dashboard

General payments

$7,120

134 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Samira El Zind of South Bend, IN is reported in the CMS Open Payments database as having received $7,120 across 134 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 78th percentile of Neurology with Special Qualifications in Child Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $830 24
2024 General $812 20
2023 General $340 9
2022 General $461 14
2021 General $745 12
2020 General $311 11
2019 General $3,620 44

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Samira El Zind
  • Neurology with Special Qualifications in Child Neurology median
  • Middle half of Neurology with Special Qualifications in Child Neurology
  • National median

In program year 2025, general payments to Samira El Zind were reported at $830. Among 1,228 Neurology with Special Qualifications in Child Neurology profiles paid that year, the median was $276 and the middle half received between $87 and $1,522.

Show as a table
Year Samira El Zind Neurology with Special Qualifications in Child Neurology median Middle half National median
2019 $3,620 $262 $68–$1,313 $163
2020 $311 $188 $46–$1,222 $114
2021 $745 $183 $45–$1,356 $132
2022 $461 $229 $72–$1,177 $149
2023 $340 $269 $93–$1,195 $160
2024 $812 $300 $98–$1,428 $164
2025 $830 $276 $87–$1,522 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. LivaNova USA, Inc. $1,996 21 payments
  2. Aquestive Therapeutics, Inc. $1,389 2 payments
  3. UCB, Inc. $1,249 33 payments
  4. Jazz Pharmaceuticals Inc. $729 14 payments
  5. Catalyst Pharmaceuticals, Inc. $383 15 payments
  6. Eisai Inc. $363 9 payments
  7. Neurelis, Inc. $356 8 payments
  8. SK Life Science, Inc. $120 1 payment
  9. Sunovion Pharmaceuticals Inc. $89 6 payments
  10. Supernus Pharmaceuticals, Inc. $87 5 payments
  11. Other $359 20 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,668 127 payments
  2. Consulting Fee $1,260 1 payment
  3. Travel and Lodging $1,183 4 payments
  4. Education $9 2 payments
Products named General payments · program years 2019–2025
  1. VNS Therapy $1,621 8 payments
  2. SYMPAZAN $1,389 2 payments
  3. Epidiolex $811 18 payments
  4. Briviact $467 17 payments
  5. FYCOMPA Neurology $383 15 payments
  6. Fycompa Neurology $363 9 payments
  7. VALTOCO $356 8 payments
  8. VNS THERAPY SENTIVA MODEL 1000 GENERATOR $242 11 payments
  9. Nayzilam $166 4 payments
  10. Fintepla $153 3 payments
  11. Other $842 37 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

134 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology with Special Qualifications in Child Neurology in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record